Get started
Author

Deeksha Muthumani

Observed name: D. Muthumani
Observed institution: University of Pennsylvania
ORCID: 0009-0006-4172-0399
Observed ORCID: 0009-0006-4172-0399
OpenAlex ID: A5092737500
Pretreatment with IL-15 and IL-18 rescues natural killer cells from granzyme B-mediated apoptosis after cryopreservation
2024 · Abdulla Berjis, Deeksha Muthumani, et al. · Nature Communications · 51
PDF
Swiss army knife T cell: one T cell many tumor targets
2023 · Abdulla Berjis, Deeksha Muthumani, et al. · Cell Research · 2
PDF
1016 Synecta™ cell-derived nanoparticles platform offers versatile use of membrane-bound and soluble cytokines for rapid and efficient CAR-T cell production
2025 · Deeksha Muthumani, Chiquita Hanindya, et al. · Regular and Young Investigator Award Abstracts · 1
PDF
Cell-Derived Nanoparticles (CDNPs) Enable Versatile, Rapid, and Robust T Cell Expansion for Scalable CAR-T Manufacturing
2025 · B.A. Sadiq, C. Zhang, et al. · Cytotherapy · 1
Enhanced antitumor efficacy through combined chimeric antigen receptor T cell therapy and CD40 stimulation in syngeneic solid tumor models
2026 · Giulia Golinelli, Ting-Jia Fan, et al. · Cytotherapy
Abstract 4291: Synecta™ T1 cell-derived nanoparticles enable accelerated, potent T cell expansion for scalable adoptive immunotherapy manufacturing
2026 · Deeksha Muthumani, Chiquita Hanindya, et al. · Cancer Research
Works count: 6
Citation count: 55
H-index: 2
I10-index: 1
Year
Topic
Type